参松养心胶囊联合美托洛尔治疗心率失常的临床疗效分析

目的：研究参松养心胶囊联合美托洛尔治疗心律失常的临床疗效。方法选取2010年3月~2013年5月我院心内科收治的心率失常患者92例，采用随机数字表法将患者分成研究组与对照组，每组46例。对照组给予单独美托洛尔治疗，研究组给予参松养心胶囊联合美托洛尔治疗。观察两组患者治疗前后的血压、心率变化情况，2个月后统计分析两组的治疗效果。结果研究组患者治疗后显效26例，有效16例，无效4例，总有效率为91.3%；对照组治疗后显效18例，有效17例，无效11例，总有效率为76.1%。两组患者治疗的总有效率差异有统计学意义（P＜0.05）。与治疗前相比，研究组治疗后患者血压、心率的差异显著，均有统计学意义（P＜0.05）；研究组患者治疗后的血压、心率相对于对照组下降的幅度更为明显，两组之间的差异有统计学意义（P＜0.05）。结论参松养心胶囊联合美托洛尔能够更加有效的控制心律失常的心室率，临床效果显著，值得推广应用。

The clinical effect analysis of Shensongyangxin capsule combined with Metoprolol in the treatment of cardiac arrhythmias

Objective To analyze clinical efficacy of Shensongyagnxin capsule combined with Metoprolol in the treatment of arrhythmia. Methods 92 cases of patients with arrhythmia were selected from March 2010 to May 2013 in cardiology department of arrhythmia in our hospital, which were randomly divided into two groups, each group had 46 cases. Control group was given Metoprolol therapy alone, treatment group was given Shensongyangxin capsule combined with Metoprolol therapy. Observed the blood pressure, heart rate before and after treatment carefully in both group, the treatment effect of the two groups were compared after 2 months. Results After the treatment, in the treatment group, 26 cases had marked effect, 16 cases effective,4 cases ineffective, the total effective rate was 91.3%. In the control group, 18 cases had marked effect, 17 cases effective, 11 cases ineffective, the total effective rate was 76.1%. The treatment effective rate between the two groups have statistical significance （P 〈0.05）. the treatment group blood pressure, heart rate compared with before treatment, the difference was statistically significant （P〈0.05）, compared with control group, the decline significantly, the difference was statistically significant（P〈0.05）. Conclusion Shensongyangxin capsule combined with Metoprolol arrhythmia id more effective to control ventricular rate. And it has significant clinical effect Clinical efficacy which is worthing to us in clinic.